p53 aerosol formulationwith low toxicity and high efficiency for early lung cancer treatment

Clinical Cancer Research

Volumn 13, Issue 16, 2007, Pages 4900-4908

  Zou, Yiyu ^a   Tornos, Carmen ^b   Qiu, Xuan ^a   Lia, Marie ^a   Perez Soler, Roman ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DRUG CARRIER; FLUORESCENT DYE; POLYLYSINE; POLYLYSINE PROTAMINE COMPLEX; PROTAMINE; PROTEIN P53; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; XENOGRAFT; ANIMAL; CHEMISTRY; GENE THERAPY; GENE TRANSFER; INSTITUTE FOR CANCER RESEARCH MOUSE; LUNG TUMOR; PLASMID; TUMOR SUPPRESSOR GENE;

AEROSOLS; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMISTRY, PHARMACEUTICAL; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, P53; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED ICR; PLASMIDS; POLYLYSINE; PROTAMINES;

EID: 34548094015     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0395     Document Type: Article

References (32)

1. Abratt RP. Current chemotherapy of advanced non-small cell lung cancer. Anticancer Drugs 1995;6:15-8.
2. Lee HY, Suh YA, Lee JI, et al. Inhibition of oncogenic K-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer. Clin Cancer Res 2002;8:2970- 5.
3. Kim HW, Park IK, Cho CS, et al. Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras nullmice. Cancer Res 2004;64:7971-6.
4. Jia SF, Worth LL, Densmore CL, Xu B, Duan X, Kleinerman ES. Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases. Clin Cancer Res 2003;9:3462-8.
5. Khanna C, Anderson PM, Hasz DE, Katsanis E, Neville M, Klausner JS. Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. Cancer 1997;79:1409-21.
6. Anderson PM, Markovic SN, Sloan JA, et al. Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases. Clin Cancer Res 1999;5:2316-23.
7. Verschraegen CF, Gilbert BE, Huaringa AJ, et al. Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs. Ann N Y Acad Sci 2000;922:352-4.
8. Koshkina NV, Kleinerman ES. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases. Int J Cancer 2005;116:458-63.
9. Haynes A, Shaik MS, Chatterjee A, Singh M. Formulation and evaluation of aerosolized celecoxib for the treatment of lung cancer. Pharm Res 2005;22:427-39.
10. Swisher SG, Roth JA. Nemunaitis J. et al. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst 1999;91:763-71.
11. Schuler M, Herrmann R, De Greve JL, et al. Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol 2001;9:1750-8.
12. Bykov VJ, Wiman KG. Novel cancer therapy by reactivation of the p53 apoptosis pathway. Ann Med 2003;35:458-65.
13. Viktorsson K, De Petris L, Lewensohn R. The role of p53 in treatment responses of lung cancer. Biochem Biophys Res Commun 2005;331:868-80.
14. Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF. Apoptosis and lung cancer: a review. J Cell Biochem 2003;88:885-98.
15. Ventura A, Kirsch DG, McLaughlin ME, et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007;445:661-5.
16. Xue W, Zender L, Miething C, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007;445:656-60.
17. Zou Y, Zong G, Ling YH, et al. Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes. J Natl Cancer Inst 1998;90:1130-7.
18. Toguchida J, Yamaguchi T, Dayton SH, et al. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 1992;326:1301-8.
19. Bhatia K, Gutierrez MI, Huppi K, Magrath IT. PCR detection of a neutral CGA/CGG dimorphism in exon 6 of the human p53 gene. Nucleic Acids Res 1992;20:928.
20. Brodeur GM, Pelletier J, Gros P. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 1993;53:5269-73.
21. Carbone D, Chiba I, Mitsudomi T. Polymorphism at codon 213 within the p53 gene. Oncogene 1991;6:1691-2.
22. Zou Y, Zong G, Ling YH, Perez-Soler R. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer. Cancer Gene Ther 2000;7:683-96.
23. Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 1997;15:647-52.
24. Bates DV, Fish BR, Hatch TF, Mercer TT, Morrow PE. Deposition and retention models for internal dosimetry of the human respiratory tract. Task group on lung dynamics. Health Phys 1966;12:173-207.
25. Davies DS. Pharmacokinetics of inhaled substances. Scand J Respir Dis Suppl 1979;103:44-9.
26. Xu L, Pirollo KF, Chang EH. Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. J Control Release 2001;74:115-28.
27. Lin X, Ramamurthi K, Mishima M, Kondo A, Christen RD, Howell SB. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin. Cancer Res 2001;61:1508-16.
28. Roth JA, Grammer SF, Swisher SG, Nemunaitis J, Merritt J, Meyn RE, Jr. Gene replacement strategies for treating non-small cell lung cancer. Semin Radiat Oncol 2000;10:333-42.
29. Colletier PJ, Ashoori F, Cowen D, et al. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation. Int J Radiat Oncol Biol Phys 2000;48:1507-12.
30. Gautam A, Waldrep JC, Kleinerman ES, et al. Aerosol gene therapy for metastatic lung cancer using PEI-p53 complexes. Methods Mol Med 2003;75:607-18.
31. Densmore CL, Kleinerman ES, Gautam A, et al. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes. Cancer Gene Ther 2001;8:619-27.
32. Gautam A, Waldrep JC, Densmore CL, et al. Growth inhibition of established B16-10 lung metastases by sequential aerosol delivery ofp 53 gene and 9-nitrocamptothecin. Gene Ther 2002;9:353-7.